Harvard Bioscience (HBIO) Net Margin (2010 - 2026)
Harvard Bioscience (HBIO) reported Net Margin of 16.5% for Q1 2026, up 21448.0% year-over-year from N/an in Q1 2025, and down 15.17% quarter-over-quarter from 14.32% in Q4 2025.
Harvard Bioscience (HBIO) Net Margin (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 16 years of Net Margin data on file, last reported at 16.5% in Q1 2026.
- Net Margin for Q1 2026 came in at 16.5%, up 21448.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 12.09% (up 5133.0% YoY), and the FY2025 annual result was 66.15%, down 5297.0% from the prior year.
- Net Margin slipped to 16.5% in Q1 2026 per HBIO's latest filing, from 14.32% in the prior quarter.
- Over five years, Net Margin peaked at 8.34% in Q2 2022 and troughed at 230.98% in Q1 2025.
- A 5-year average of 22.36% and a median of 11.16% in 2025 frame the typical range for Net Margin.
- The sharpest annual moves came in 2025 and 2026: Net Margin tumbled 21183 bps in 2025, then soared 21448 bps in 2026.
- A 5-year view of Net Margin shows it stood at 7.61% in 2022, then increased by 26 bps to 5.65% in 2023, then jumped by 101 bps to 0.07% in 2024, then tumbled by 19642 bps to 14.32% in 2025, then decreased by 15 bps to 16.5% in 2026.
- Business Quant data shows HBIO's Net Margin at 16.5% in Q1 2026, 14.32% in Q4 2025, and 5.98% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 29.81% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -5.81% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 3.25% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 27.86% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 16.03% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 0.65% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -7.20% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 10.84% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 0.07% |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | -16.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.50% |
| Dec 31, 2025 | -14.32% |
| Sep 30, 2025 | -5.98% |
| Jun 30, 2025 | -11.16% |
| Mar 31, 2025 | -230.98% |
| Dec 31, 2024 | 0.07% |
| Sep 30, 2024 | -21.86% |
| Jun 30, 2024 | -12.47% |
| Mar 31, 2024 | -19.15% |
| Dec 31, 2023 | -5.65% |
| Sep 30, 2023 | -4.89% |
| Jun 30, 2023 | -3.41% |
| Mar 31, 2023 | 2.08% |
| Dec 31, 2022 | -7.61% |
| Sep 30, 2022 | -12.65% |
| Jun 30, 2022 | 8.34% |
| Mar 31, 2022 | -24.04% |
| Dec 31, 2021 | 1.78% |
| Sep 30, 2021 | -0.57% |
| Jun 30, 2021 | -1.48% |